Akero Therapeutics, Inc. (AKRO) Financials
Stock symbol AKRO is outdated, potentially delisted? Maybe it is available on other exchange?
AKRO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 580.3 million | 45.0 million |
| Sept. 30, 2023 | 635.3 million | 52.2 million |
| June 30, 2023 | 663.8 million | 47.4 million |
| March 31, 2023 | 348.8 million | 42.5 million |
AKRO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -48.6 million | 6.1 million |
| Sept. 30, 2023 | -49.7 million | 5.7 million |
| June 30, 2023 | -22.4 million | 4.8 million |
| March 31, 2023 | -24.6 million | 4.8 million |
AKRO Net Income
No data available :(
AKRO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 550.0 million | - | 1.3 million |
| Sept. 30, 2023 | 554.7 million | - | 1.4 million |
| June 30, 2023 | 639.4 million | - | 1.4 million |
| March 31, 2023 | 343.2 million | 24.6 million | 1.4 million |
AKRO Shares Outstanding
AKRO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | - | 53.4 million | 8.5 million | 2000 |
| Sept. 30, 2023 | - | 38.6 million | 8.0 million | - |
| June 30, 2023 | - | 28.0 million | 7.6 million | - |
| March 31, 2023 | - | 21.8 million | 7.0 million | - |
AKRO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 284000 | 2000 |
| Sept. 30, 2023 | - | 5000 |
| June 30, 2023 | - | 69000 |
| March 31, 2023 | - | 68000 |
AKRO
Price: $54.65
52 week price:
Earnings Per Share: -3.75 USD
P/E Ratio: -14.52
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 143289
Market Capitalization: 4.5 billion